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Plasma membrane repair involves the coordinated
effort of proteins and the inner phospholipid surface
to mend the rupture and return the cell back to
homeostasis. Here, we present the three-dimen-
sional structure of a multiprotein complex that
includes S100A10, annexin A2, and AHNAK, which
along with dysferlin, functions in muscle and cardiac
tissue repair. The 3.5 A˚ resolution X-ray structure
shows that a single region from the AHNAK
C terminus is recruited by an S100A10-annexin A2
heterotetramer, forming an asymmetric ternary
complex. The AHNAK peptide adopts a coil confor-
mation that arches across the heterotetramer con-
tacting both annexin A2 and S100A10 protomers
with tight affinity (30 nM) and establishing a struc-
tural rationale whereby both S100A10 and annexin
proteins are needed in AHNAK recruitment. The
structure evokes a model whereby AHNAK is tar-
geted to themembrane surface through sandwiching
of the binding region between the S100A10/annexin
A2 complex and the phospholipid membrane.
INTRODUCTION
The plasma membrane is the physical boundary that separates
the intracellular components from the extracellular environment.
Although the membrane allows the selective passage of small
molecules, its major roles are to maintain homeostasis, to main-
tain the integrity of internal organelles, and to protect against
entry of toxins. Some cells, especially those in muscle tissue
are subject to frequent tearing, disrupting the cell membrane.
Diseases, such as limb-girdle muscular dystrophy and a variety
of myopathies, have been linked to the mutation of proteins
involved in membrane repair (Bansal et al., 2003; Illarioshkin
et al., 2000; Liu et al., 1998). Dysferlin is one such protein that
has been shown to bind with phospholipids in a Ca2+-dependent
manner and appears to function by mediating vesicle clustering
and fusion with the plasma membrane (Davis et al., 2002) (Cen-
acchi et al., 2005). The absence of dysferlin in mouse model
systems prevents the resealing of plasma membranes (Han
et al., 2007; Humphrey et al., 2012). These observations areStructure 20, 1737–1consistent with one model for membrane repair whereby
multiple proteins, including dysferlin, mediate the fusion of an
exocytotic compartment to the inner surface of the membrane,
thereby expanding and resealing the membrane (Draeger
et al., 2011; Han and Campbell, 2007; Idone et al., 2008).
Enlargeosomes are one type of exocytotic vesicle implicated
in membrane repair because of their rapid calcium-dependent
translocation from the cytosol to the plasma membrane surface
immediately following membrane damage (Borgonovo et al.,
2002; Cocucci et al., 2004, 2007). Associated with enlargeo-
somes is AHNAK, a component of themembrane repair complex
that interacts with dysferlin (Cacciottolo et al., 2011; de Morre´e
et al., 2010; Huang et al., 2007, 2008). AHNAK colocalizes with
dysferlin at the plasma membrane (Huang et al., 2007), and
siRNA knockdown experiments of AHNAK inhibit membrane
clustering and fusion (Han et al., 2012). In patients with limb-
girdle muscular dystrophy caused by mutation of the dysferlin
gene, AHNAK no longer localizes to the plasma membrane in
muscle cells (Zacharias et al., 2011).
The enlargeosome and plasma membrane surfaces are also
characterized by localization of the calcium-binding protein an-
nexin A2, a protein required for exocytosis, membrane aggrega-
tion (Harder and Gerke, 1993, 1994; Illien et al., 2010; Lorusso
et al., 2006), and the fusing of two adjacent surfaces (Lennon
et al., 2003; McNeil et al., 2006). Annexin A2 has been shown
to associate with dysferlin by coimmunoprecipitation, and both
proteins colocalize at the plasma membrane (Lennon et al.,
2003). Annexin A2 was originally identified as a component of
a heterotetrameric complex with S100A10 (also known as p11)
(Gerke and Weber, 1985; Glenney and Tack, 1985), a member
of the EF-hand S100 family. An S100A10 dimer can coordinate
two annexin A2 proteins through a high-affinity interaction with
the N terminus of each annexin protein (Becker et al., 1990;
Glenney et al., 1986; Johnsson et al., 1988). Upon membrane
rupture and calcium influx annexin, A2 localizes to the plasma
membrane through phospholipid binding (Swairjo et al., 1995).
The ability of the S100A10-annexin A2 complex to bridge adja-
cent phospholipid membranes during a membrane fusion event
has been suggested as an attractive model for membrane repair
(Gerke and Moss, 2002). Direct interaction between S100A10,
AHNAK, and annexin A2 has been observed in coimmunopreci-
pitation and yeast three-chimeric experiments, whereas knock-
down of either S100A10 or annexin A2 prevents AHNAK from
localizing to the membrane (Benaud et al., 2004; De Seranno
et al., 2006). Further, proteomic studies have identified AHNAK,
annexin A2, and S100A10 as constituent proteins of the dysferlin745, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1737
Figure 1. Asymmetry of AHNAK Binding to A10A2 Shown by NMR Spectroscopy
(A and B) Regions of the 600 MHz 1H-15N HSQC spectra for 15N-labeled A10A2 (400 mM) in the absence (dark contours) and presence (light contours) of AHNAK
peptide (550 mM).
(C) The assigned 1H-15N HSQC spectrum of A10A2 in complex with the AHNAK peptide. Nonequivalent pairs of residues are indicated by residue and sequence
number (i.e., A76, A76’). Residues S101–D115 in A10A2 correspond to residues S1–D15 in annexin A2.
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Ternary Membrane Repair Complex Structuremembrane repair complex (Cacciottolo et al., 2011; de Morre´e
et al., 2010; Leung et al., 2011). Finally, a high-affinity ternary-
complex has been identified involving the C terminus of AHNAK
with the S100A10-annexin A2 heterotetramer (Rezvanpour
et al., 2011).
Membrane repair requires an array of protein-protein interac-
tions near the inner plasma membrane surface and exocytotic
vesicles, such as enlargeosomes, to coordinate the resealing
process. In this work we describe the 3.5 A˚ resolution crystal
structure of the ternary complex between S100A10, the
N terminus of annexin A2 and the binding region from the enlar-
geosome protein AHNAK. To our knowledge, this is the first
structure showing how these three proteins interact prior to
association with a membrane required for the repair process.
RESULTS AND DISCUSSION
The assembly of a heterotetrameric complex between S100A10
and annexin A2 has been shown previously to require only the
first ten residues from annexin A2 (Becker et al., 1990). To facil-
itate a stable complex, we constructed a tandem chimeric
protein linking the C terminus of S100A10 to the N-terminal 15-
residues of annexin A2 separated by a nine-residue tether
(A10A2). Comparison of 1H-15N HSQC spectra shows the
assembly of this chimeric A10A2 protein is very similar to that
of the heterotetrameric noncovalent complex that includes
S100A10 and two 14-residue annexin A2 peptides (Rezvanpour1738 Structure 20, 1737–1745, October 10, 2012 ª2012 Elsevier Ltdet al., 2009). A variety of in vivo and in vitro studies have shown
that a small region (G5654–L5673) within the 1,000-residue
C terminus of AHNAK interacts with high affinity (30 nM) with
the S100A10-annexin A2 complex or A10A2 (Benaud et al.,
2004; De Seranno et al., 2006; Rezvanpour et al., 2011). To iden-
tify how S100A10, annexin A2, and AHNAK interact simulta-
neously the three-dimensional structure was determined of
a 20-residue peptide from AHNAK (residues G5654-L5673) in
conjunction with the A10A2 chimeric protein.
NMR Experiments Show the Asymmetric Recruitment
of AHNAK
The interaction between AHNAK and A10A2 was initially charac-
terized by nuclear magnetic resonance (NMR) spectroscopy. In
the absence of the AHNAK peptide the 1H-15N HSQC of A10A2
showed single resonances for residues in both the S100A10
and annexin A2 moieties consistent with the symmetrical nature
of the complex (Figure 1). Addition of unlabeled AHNAK peptide
(G5654–L5673) to a solution of 15N, 13C-labeled A10A2 resulted
in an increased number of peaks, many as pairs, with each signal
having about 50% of the original peak intensity (Figure 1). For
example, V66 and A76 in the S100A10 moiety, and G99 and
G114 in the annexin A2 segment of A10A2, are initially present
as single resonances in 1H-15N HSQC spectra but result in two
signals upon addition of AHNAK peptide. Assignment of the
A10A2-AHNAK complex using triple-resonance experiments
indicated that the paired signals arose from identical residuesAll rights reserved
Table 1. Data Collection and Model Refinement Statistics
Data Collection
Wavelength (A˚) 1.100
Resolution limitsa (A˚) 43.34–3.26 (3.32–3.26)
Space group P1
Unit-cell constants
a, b, c (A˚) 47.76, 47.79, 62.82
a, b, g () 71.62, 71.63, 68.62
Number of unique reflections 7,306 (386)
Redundancy 3.8 (3.7)
Completeness (%) 98.6 (100.0)
Rsym (%) 8.9 (45.5)
I / s(I) 8.9 (3.1)
Wilson B (A˚2) 124.19
Model Refinement
Resolution range (A˚) 43.34–3.50
Rwork / Rfree (%) 29.63 / 32.67
Number of nonhydrogen atoms per asymmetric unit
(average B factors, A˚2)
Protein 3,496 (154.60)
Solvent N/A
Rmsd from ideal geometry
Bond lengths (A˚) 0.014
Bond angles () 1.165
Ramachandran statistics
Most favored (%) 73.7
Additional allowed (%) 24.7
Generously allowed (%) 1.3
Disallowed (%) 0.3
aNumbers in the parentheses refer to the highest resolution bins.
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Ternary Membrane Repair Complex Structurein S100A10 and annexin A2 that experienced two different envi-
ronments when in complex with AHNAK (Figure 1). This observa-
tion is indicative of an asymmetric binding arrangement for the
AHNAK peptide with respect to A10A2. This conclusion is in
agreement with previous titration experiments using fluores-
cence spectroscopy and isothermal calorimetry (Rezvanpour
et al., 2011) that show a stoichiometry of one AHNAK peptide
per A10A2 tetrameric complex.
Three-Dimensional Structure of A10A2-AHNAK Peptide
Diffraction-quality crystals of the A10A2-AHNAK complex were
obtained using the hanging-drop vapor diffusion method. Crys-
tals grew in the space group P1, diffracted to 3.5 A˚ and con-
tained two copies of the complex linked by disulfide bonds
between chains A-C and B-D. Similar disulfide bonding was
observed in the structure of S100A10 (Re´ty et al., 1999). The
initial Fo-Fc electron density map following molecular replace-
ment clearly indicated the presence of a single extended peptide
within each copy of the A10A2 complex (Figure S1 available on-
line; Table 1). Electron density for the peptide was of sufficient
quality to identify residues with bulky hydrophobic side chains.
As a result the orientation of the peptide is well defined, despite
themedium resolution of the structure. The data allowed fitting ofStructure 20, 1737–1residues P1–K91 in the S100A10 portion of all four chains and
S101–L112 (chains A and C) and S101’–E113’ (chains B and D)
within the annexin A2 portion of A10A2. The nine-residue linker
connecting S100A10 to the annexin A2 peptide was dynamically
disordered and not modeled in the final structure, suggesting
that this region does not associate with either of the protein
components in the A10A2 complex. The structure of each
complex differed only slightly (backbone rmsd 0.2 A˚), and there-
fore only one complex is described further.
The structure shows a symmetrical arrangement of the
S100A10 dimer (Figure 2) with each of the two protomers
comprising four a helices (I, Q3–A19; II, K27–K36; III, A50–L58;
IV, F68–V88; also I’–IV’) that make up the EF-hand motifs, sepa-
rated by a 12-residue linker containing a short helix (aL, aL’),
observed in some other S100 proteins. Helices I and IV (I’, IV’)
comprise the S100A10 dimer interface, forming an X-type
bundle originally described for calcium-free S100A6 (Potts
et al., 1995). The two N-terminal annexin A2 regions of the
A10A2 dimer form a-helical structures (V103 to S108) positioned
on opposite sides of the S100A10 protein within a hydrophobic
groove formed by helices IV (IV’) and aL (aL’). The N terminus
(V103, V103’) of annexin A2 lays across helix I (I’) of the symmet-
rically related protomer, thereby bridging the S100A10 dimer.
The overall structure of the A10A2 chimeric protein within the
ternary complex agrees well with the parent complex (Re´ty
et al., 1999) in the absence of AHNAK (backbone rmsd 1.02 A˚).
This indicates that AHNAK binding to the A10A2 complex
does not cause a large structural rearrangement within the
heterotetramer.
Consistent with NMR observations, only one AHNAK peptide
is present in the A10A2 complex. Although the peptide used in
crystallization trials comprised 20 residues, only residues
P5659-F5668 were visible in the complex (Figure S1). The AH-
NAK peptide adopts a coil conformation that arches across
helices IV and IV’ with its N termini and C termini adjacent to
helices III and aL, and III’ and aL’, respectively, of the
S100A10 protein (Figure 2). Both the N termini and C termini of
AHNAK are in contact with the C termini of both annexin A2
segments. This places residues at the center of AHNAK
(I5663, P5664) near the axis of the helix IV-IV’ crossing point
(S73, G77, S73’, G77’). Moving outward, the N- and C-terminal
residues in AHNAK, although different in sequence, have nearly
identical contacts with S100A10 and annexin A2 across the
interface. This imparts a pseudosymmetric quality to the struc-
ture. For example, P5659 packs between residues on helices
aL (F41), IV (G77, L78, A81) and annexin A2 (L110, L112)
compared with F5668 that has interactions with aL’ (F41’), IV’
(G77’, L78’, A81’) and annexin A20 (L110’, L1120) on the opposite
side of the complex. Similarly, the side chain of M5661 sits
among side chains of residues on helices III (I54) and IV (L74,
L78), while residue F5666 has contacts with similar residues
on the partner protomer. Most of these residues in S100A10
and annexin A2 also experience the largest chemical shift
changes and peak duplication upon AHNAK binding observed
in NMR experiments (Figure 1). The AHNAK interaction buries
about 670 A˚2 of side chain surface area, partitioned among
S100A10 (535 A˚2) and annexin A2 (135 A˚2). This shows that
both the S100A10 and annexin A2 moieties are required for
AHNAK recruitment.745, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1739
Figure 2. The Structure of the A10A2-AH-
NAK Ternary Complex
(A) Ribbon diagram of the complex indicating the
two S100A10 protomers (blue, cyan), the two an-
nexin peptides (green, orange), and the bound
AHNAK peptide (magenta). Only the side chains in
the AHNAK peptide are shown for clarity. Resi-
dues in AHNAK with key interactions with A10A2
are labeled.
(B) Ribbon diagram from (A) rotated approximately
90 around the x axis showing that AHNAK bends
across helices IV and IV’ with its N termini and C
termini surrounded by helices IV (IV’), III (III’), aL
(aL’), and the C termini of both annexin A2
peptides.
See also Figure S1.
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S100A10-annexin A2 does not resemble any other binding
arrangement used by an S100 protein. For example, structures
of S100B with peptides derived from p53 (Rustandi et al.,
2000) or Ndr kinase (Bhattacharya et al., 2003) utilize a hydro-
phobic cleft formed by helices III and IV (III’, IV’) from each pro-
tomer, as opposed to AHNAK that crosses helices IV and IV’.
Recently, a binary complex between S100A4 and nonmuscle
myosin IIA showed the myosin peptide also bound across
helices IV and IV’ of S100A4 (Elliott et al., 2012; Kiss et al.,
2012). Unlike the coil structure adopted by AHNAK, the myosin
peptide uses a longer binding sequence and takes on an
a-helical structure in the complex. Further, in the A10A2 assem-
blage with AHNAK both the S100A10 and annexin A2 proteins
each make contact with AHNAK, indicating that both proteins
are necessary for ternary complex formation. This conclusion
corroborates findings that AHNAK displays poor binding with
S100A10 alone but displays a dissociation constant near
30 nM in the presence of the N terminus of annexin A2 (De Ser-
anno et al., 2006; Rezvanpour et al., 2011).
Identification of Key Residues at the A10A2 Interface
with AHNAK
A peptide array experiment was used to identify residues in
AHNAK that are important for formation of the A10A2-AHNAK
complex (Figure 3). In two separate experiments, all 20 naturally
occurring amino acids were systematically substituted at each
position of the AHNAK peptide, synthesized as spots on a nitro-
cellulose membrane, and probed with fluorescently labeled
A10A2. The majority of positions in AHNAK showed little differ-
ence in fluorescence intensity compared to the wild-type
sequence, indicating these residues were unaffected by substi-
tution. However, several key residues were identified, including
I5663, P5664, F5666, and F5668, that reproducibly showed
poorer binding for A10A2 based on decreased fluorescence
intensity for individual spots. In particular, substitution of either
F5666 or F5668 in AHNAK to any residue type other than a large
aromatic, resulted in nearly complete loss of A10A2 binding.
These two aromatic residues in AHNAK appear as the key
anchoring residues for its interaction with A10A2 having multiple
hydrophobic contacts with both S100A10 and annexin A2.
Residue P5664 was also selective showing poorer binding for
most polar residues (K, H, R, E, Q, S, T, A, G). In general these1740 Structure 20, 1737–1745, October 10, 2012 ª2012 Elsevier Ltdobservations agreed with the key hydrophobic residues in
AHNAK (P5664, F5666, F5668) located at the interface of the
A10A2 structure (Figure 2). One anomaly was P5659 that showed
little sensitivity toward substitutions, perhaps indicating that the
N-terminal portion of the AHNAK binding sequence makes
a smaller contribution to the overall association with S100A10-
annexin A2.
Results from the crystal structure and peptide array experi-
ments identified several key residues in S100A10 and annexin
A2 at the interface with AHNAK. In particular S73 and S73’
appear to act as ‘‘guideposts’’ that funnel the AHNAK peptide
across G77 and G77’ of helices IV and IV’, allowing residues
I5663 and P5664 from AHNAK to move into close contact with
S100A10 (Figure 4). In addition, the hydroxyl side chains of
S73 and S73’ are positioned to form hydrogen bonds with the
carbonyl oxygens of K5662 and K5665 in AHNAK. To test the
importance of S73 and G77 in S100A10 toward AHNAK complex
formation these two positions were exchanged (S73G, G77S;
A10A2-GS). This should have the effect of changing the angle
the AHNAK peptide might adopt upon crossing helices IV
and IV’, perhaps limiting the ability of the N- and C-terminal
regions of AHNAK to contact the C termini of both annexin A2
segments. Rather than restricting experiments to the short
20-residue peptide-binding region, affinity experiments were
completed using a 320-residue C-terminal fragment of AHNAK
(AHNAK5362–5681) and a set of substituted GST-tagged A10A2
proteins. The results showed that wild-type GST-A10A2 bound
to AHNAK5362–5681 (Figure 4). Upon swapping residues S73
and G77, binding of AHNAK5362–5681 to A10A2-GS was repro-
ducibly reduced by about 60%, indicating that the arrangement
of these residues is important for maintaining the trajectory of the
AHNAK peptide across helices IV and IV’. A further L112A substi-
tution (A10A2-GSA) was made in the annexin A2 region of
A10A2. This residue sits adjacent to P5659 (L112) and F5668
(L1120) at the N termini and C termini of AHNAK in the ternary
complex (Figure 4) but does not participate in S100A10-annexin
A2 complex formation (Becker et al., 1990; Re´ty et al., 1999),
indicating its positioning is unique to the recruitment of AHNAK.
When combined with the S73, G77 exchange substitutions,
substitution at L112 showed that binding to AHNAK was nearly
abolished (>90% reduction).
The three substitutions made in A10A2 indicate that S73 and
G77 in S100A10 and L112 in annexin A2 are integral for AHNAKAll rights reserved
Figure 3. Permutation Peptide Array Showing Key Residues in
AHNAK Required for Ternary Complex Formation
AHNAK peptides (20 residues each) were synthesized on a membrane spot
array. Substitutions cycle through the naturally occurring amino acids at every
position in the AHNAK peptide sequence. The column marked ‘‘WT’’ (far right)
contains spots from the wild-type peptide for comparison. The array was
probed with 5 nM Alexa-680 labeled A10A2 that fluoresces red.
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protein assembly. An examination of other S100 protein
sequences (Figure S2) shows that only S100A10 possesses
the S73/G77 ‘‘guideposts’’ on the surface of helices IV and IV’
used to funnel AHNAK across these helices. Typically, the S73
position is occupied by larger residues (V, F) in other S100
proteins and is rarely combined with a glycine residue as
observed in S100A10. In addition, the tandem pair of leucine
residues (L110, L112) in the N-terminal region of annexin A2 is
instrumental in recruiting AHNAK through interactions with
F5668. These leucine residues are only found in annexins A2
and A9 (Figure S2), although annexin A9 does not appear to
interact with S100A10 based on proteomic analyses of at least
one membrane repair complex (de Morre´e et al., 2010). Because
other molecules, such as the epithelial calcium channel proteins
TRPV5 and TRPV6 (Borthwick et al., 2008; van de Graaf et al.,
2003) and plasminogen (Kwon et al., 2005; MacLeod et al.,
2003), are also recruited by the S100A10-annexin A2 heterote-
tramer it is likely that a similar ternary binding arrangement exists
for these complexes with S100A10-annexin A2.
In complementary reverse affinity experiments, four substitu-
tions in the C terminus of AHNAK5362–5681 at positions P5659,
I5663, P5664, and F5668 were made and tested for their interac-
tion with GST-A10A2 (Figure 4). Because the structure revealed
that AHNAK adopted a coil-type structure, glycine was used for
all substitutions to minimize potential backbone disruptions. In
the I5663G, P5664G substituted AHNAK protein (AHNAK-IP)
a 40% reduction in binding was noted to GST-A10A2 in eluted
fractions (Figure 4). A similar result occurred for the P5659G,Structure 20, 1737–1F5668G (AHNAK-PF) protein. The combination of these four
substitutions (AHNAK-PIPF) reproducibly led to a 70% decrease
in the amount of AHNAK protein bound to GST-A10A2. These
observations correspond to approximate increases in the disso-
ciation constants of 5-fold (AHNAK-IP, AHNAK-PF) and 20-fold
(AHNAK-PIPF) compared to the wild-type interaction (30 nM)
(De Seranno et al., 2006; Rezvanpour et al., 2011). These results
support the importance of I5663 and P5664 residues at the
fulcrum of the helix IV-IV’ crossing point in S100A10 (Figure 4),
nestled between the guidepost residues S73 (S73’) and G77
(G77’). The P5659 and F5668 residues in AHNAK are equidistant
from the center of the AHNAK sequence and show pseudosym-
metric contacts with F41, I54, L78, A81 (F41’, I54’, L78’, A81’)
from S100A10 and L110 and L112 (L1100, L1120) from annexin
A2 (Figures 4D and 4E). Based on the structure, substitution of
these four residues (P5659, I5663, P5664, and F5668) would
eliminate most hydrophobic contacts and binding between
AHNAK and A10A2.
Model of AHNAK Recruitment for Membrane Repair
The structure of the A10A2 ternary complex with the AHNAK
peptide provides an attractive model for their roles in membrane
repair. Although AHNAK and annexin A2 have been observed to
undergo a calcium-mediated translocation to the membrane
surface (Benaud et al., 2004; Borgonovo et al., 2002; Cocucci
et al., 2004, 2007; Lorusso et al., 2006), neither protein has
a membrane spanning sequence. Further, knockdown of either
S100A10 or annexin A2 proteins prevents AHNAK from moving
to the phospholipidmembrane surface. These observations indi-
cate a dependency for AHNAK translocation on calcium influx
and on its association with the S100A10-annexin A2 complex.
One possible mechanism to account for this could involve
calcium binding to the seven calcium-binding sites on the
surface of annexin A2. This has been proposed to release the
N terminus of the protein allowing interaction with S100A10
(Rosengarth and Luecke, 2003). Further, calcium binding to an-
nexin A2 is a requirement for its association with the inner
surface of the phospholipid membrane. These requirements
indicate the S100A10-annexin A2 heterotetramer must initially
be formed to allow sequential recruitment of AHNAK, moving it
to the phospholipid surface as observed in previous experiments
(Borgonovo et al., 2002; Cocucci et al., 2004, 2007). The orienta-
tion of the N-terminal annexin A2 region in the A10A2-AHNAK
complex is such that the calcium-binding portions of annexin
A2 lie on the on same face as the C-terminal binding region for
AHNAK (Figure 5). It is also possible that a second, lower
affinity-binding site located near the N terminus of AHNAK
(G302-E321) might also be recruited by the S100A10-annexin
A2 complex (De Seranno et al., 2006). The sequence of this
N-terminal AHNAK motif includes analogous interfacial residues
(P307, M309, V311, P312, F314, V316) to those utilized by the
C-terminal fragment studied here for A10A2 interaction. This
similarity suggests the N-terminal AHNAK binding motif would
likely adopt a similar bound conformation as the C-terminal
peptide. In either case, this could cause this portion of AHNAK
to be sandwiched between the phospholipid membrane, coordi-
nated to calcium-loaded annexin A2, and S100A10. Because
AHNAK is a very large protein (>5,000 residues) the small binding
region recruited by S100A10-annexin A2 would allow the745, October 10, 2012 ª2012 Elsevier Ltd All rights reserved 1741
Figure 4. Affinity Experiments Showing the Interaction between a C-Terminal Fragment of AHNAK (AHNAK5362–5681) with GST-A10A2
(A) AHNAK5362–5681 along with wild-type GST-A10A2 (lanes 3–5), GST-A10A2 having residues S73 and G77 swapped (A10A2-GS, lanes 6–8) or residues S73 and
G77 swapped in combination with an L112A substitution in annexin A2 (A10A2-GSA, lanes 9–11) were loaded onto glutathione Sepharose beads.
(B) GST-A10A2 was loaded onto glutathione Sepharose beads alongwith wild-type AHNAK peptide (AHNAK-WT, lanes 1–3), AHNAK having I5663G and P5664G
substitutions (AHNAK-IP, lanes 4–6), AHNAK having P5659G and F5668G substitutions (AHNAK-PF, lanes 7–9), or AHNAK having P5659G, I5663G, P5664G,
and F5668G substitutions (AHNAK-PIPF, lanes 10–12). Each series of experiments shows the total protein loaded, unbound protein obtained in the supernatant,
and bound protein upon elution with glutathione.
(C–E) Highlighted residues in A10A2 and AHNAK involved in the interactions.
See also Figure S2.
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Ternary Membrane Repair Complex Structureremainder of the AHNAK protein to participate in additional
protein interactions, including those with dysferlin. This model
is consistent with the proposed scaffolding role for AHNAK to
recruit multiple repair molecules to the surface of the phospho-
lipid membrane.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The expression/purification of the S100A10-annexin A2 chimeric protein
(A10A2) has been previously described (Rezvanpour et al., 2009). Briefly, the
A10A2 protein contains residues 1–92 from rabbit S100A10 (100% amino
acid sequence identity with the human protein), a nine-residue linker
(93–100 that contains a tobacco-etch mosaic virus (TEV) cleavage site
followed by the N-terminal 15 residues (101–115) from annexin A2. Unlabeled
and uniformly 15N, 13C-labeled GST-tagged human A10A2 were overex-
pressed and purified in the BL21 (DE3)-RIL Escherichia coli strain. For affinity
experiments, the GST purification tag was not cleaved from the A10A2 protein.
A10A2 proteins all contained the C82S substitution for continuity with previous
work (Rezvanpour et al., 2011). The substitutions L112A (A10A2-A), S73G,
G77S (A10A2-GS), and S73G,G77S,L112A (A10A2-GSA) were produced
using the QuikChange protocol (Stratagene, La Jolla, CA, USA).
A gene construct encoding residues 5362–5681 of human AHNAK was
synthesized by DNA2.0 (Menlo Park, CA, USA) and placed in a pJexpress411
vector with a TEV protease cleavage site between the AHNAK protein and
an N-terminal 6x-His tag. Substitution mutations P5659G, F5668G (AHNAK-
PF), I5663G, P5664G (AHNAK-IP), and P5659G, I5663G, P5664G, F5668G
(AHNAK-PIPF) were created using the QuikChange protocol (Stratagene, La
Jolla, CA). AHNAK proteins were expressed using E. coli BL21(DE3) cells
grown in Luria-Bertani (LB) media. At OD600 = 0.6 protein expression was
induced with 1mM IPTG for 4 hr at 37C. Cells were resuspended in buffer
(50 mM NaHPO4, 500 mM NaCl, and 25 mM Imidazole [pH 7.4]) and lysed
by emulsification (Avestin, Ottawa, ON, Canada). The lysate was clarified by
ultracentrifugation and then applied to Ni-NTA agarose (Qiagen, Mississauga,1742 Structure 20, 1737–1745, October 10, 2012 ª2012 Elsevier LtdON, Canada). The agarose was washed extensively, and then bound protein
was eluted using buffer supplemented with 250 mM Imidazole. Masses of all
proteins were confirmed by ESI-MS (UWO Biological Mass Spectrometry
Laboratory). The AHNAK peptide (GKVTFPKMKIPKFTFSGREL) was synthe-
sized with N-terminal acetylation and C-terminal amidation (Bio Basic Inc.,
Toronto, Canada).
NMR Spectroscopy
NMR experiments were collected on a Varian INOVA 600 MHz spectrometer
using a pulsed-field gradient triple-resonance probe at 35C. Samples of
uniformly 15N, 13C-labeled A10A2 (400 mM) or selectively labeled 15N-labeled
A10A2 proteins (40–110 mM) were prepared in 20 mM MOPS, 1 mM EDTA,
1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100 mM NaCl, and 90%
H2O/10% D2O at pH 7.0. AHNAK peptide was added at approximately 10%
excess compared to the A10A2 dimer concentration to ensure saturation.
1H-15N HSQC spectra were collected using the sensitivity-enhanced method
(Kay et al., 1992). Backbone resonance assignments for the A10A2-AHNAK
peptide complex were completed using standard triple-resonance methods
(Grzesiek and Bax, 1992; Kay et al., 1990; Wittekind and Mueller, 1993). All
data were processed and analyzed using NMRPipe/NMRDraw (Delaglio
et al., 1995) and NMRView (Johnson and Belvins, 1994).
Crystallization and Structure Determination
The A10A2-AHNAK peptide complex was purified using aHiPrep 26/10 desalt-
ing column (GE Healthcare, Uppsala, Sweden) equilibrated in 50 mM Tris-HCl
and 1 mM DTT at pH 7.5. Crystals of the complex were obtained using the
hanging-drop vapor diffusion method using the A10A2-AHNAK complex
(8mg/ml) mixedwith an equal volume (1 ml) of precipitant (Qiagen Nucleix Suite
#85: 100 mM NaCl, 200 mM MgCl2, and 0.05 M (CH3)2AsO2Na, 20% [w/v]
PEG-1000 [pH 6.5]), and crystallization additive (Hampton Research Additive
Screen #68: 0.15 mM CYMAL-7, 0.2 ml). The reservoir contained 1.5 M
(NH4)2SO4 (500 ml). Diffraction-quality crystals (200 3 200 3 100 mm
3) grew
in about five days at 20C and were flash-cooled in liquid nitrogen prior to
data collection. X-ray diffraction data were collected at Beamline X25All rights reserved
Figure 5. Model of AHNAK Recruitment to the Phospholipid Mem-
brane by the S100A10-Annexin A2 Complex
The model shows S100A10 (gray) in complex with the N-terminal region of
annexin A2 (orange, green) and the C-terminal binding region from AHNAK
(space filled, magenta, residues 5654–5673). The calcium-binding core region
of annexin A2 is shown in its calcium-bound state (2HYW), the active state for
its association with a phospholipid membrane (top). The N-terminal region of
annexin A2 bound to S100A10 shown in the structure is separated by only 15
residues from the core region, indicating the two proteins must be in close
proximity. The 700 kDa protein AHNAK (magenta) is depicted schematically to
show its 250-residue N-terminal domain (N), three central 500-residue repeat
sections (M1, M2, and M3), and 1,000 residue C terminus that includes the
S100A10-annexin A2 binding sequence. Based on the model, derived from
the A10A2 structure in complex with the AHNAK peptide, the S100A10 and
annexin A2 proteins would sandwich the AHNAK binding region near the
phospholipid membrane, leaving the remainder of AHNAK to employ its
scaffolding role.
Structure
Ternary Membrane Repair Complex Structure(equipped with an ADSC Q315 CCD detector) at the National Synchrotron
Light Source in Brookhaven National Laboratory. X-ray diffraction data was
indexed, scaled, and merged using HKL-2000 (Otwinowski and Minor,
1997). Initial phases were obtained by molecular replacement, using the struc-
ture of p11 bound to an annexin A2 N-terminal peptide as search model (PDB
ID code 1BT6) (Re´ty et al., 1999). Molecular replacement and model refine-
ment were performed using PHENIX (Adams et al., 2010) and CNS (Bru¨nger
et al., 1998), respectively. During refinement, the structural model was
adjusted manually when needed using Coot (Emsley et al., 2010). The stereo-
chemical quality of the structural model was assessed using PROCHECK (Las-
kowski et al., 1993). Structural comparison (backbone rmsd) calculations and
graphical representations of the structural model were prepared using PyMOL
(Version 1.2r2, Schro¨dinger, LLC). The interactions between A10A2 and the
AHNAK peptide were analyzed using the program VADAR (Volume, Area,
Dihedral Angle Reporter) (Willard et al., 2003).
Protein Affinity Experiments
For GST-based affinity experiments, all proteins were dialyzed into three
changes of PBS buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM NaCl,
and 2.7 mM KCl [pH 7.3]) supplemented with 0.5 mM EDTA and 0.5 mM
TCEP. GST-A10A2 and AHNAK proteins (5 mM each) were mixed and incu-
bated for 20 min at 20C. Protein mixtures were added to loose glutathione
Sepharose 4B beads (80 ml) (GE Healthcare) equilibrated in PBS buffer and
incubated at 20C for an additional 20 min with gentle rocking. Beads were
washed three times with PBS buffer (500 ml) and bound protein eluted with
a 50 mM Tris, 20 mM glutathione solution at pH 8.0 (160 ml). Samples of the
applied protein mixture, unbound and eluted proteins were separated on
10% Tris-Tricine gels and assessed by densitometry.
Peptide Array Experiments
Permutation peptide array experiments used a series of 20-residue AHNAK
peptides (residues 5654–5673). Each peptide was synthesized on a nitrocellu-
lose membrane using an Auto-Spot robot ASP222 (Amimed, London, UK)
using F-moc chemistry. Every position in the AHNAK peptide was systemati-
cally substituted with each of the 20 naturally occurring amino acids. TheStructure 20, 1737–1resulting spot array was 20320 with an additional control column representing
the wild-type AHNAK peptide. A10A2-C82S protein was fluorescently labeled
with AlexaFluor 680 maleimide, as described previously, (Invitrogen, Eugene,
OR, USA) on Cys62 (Rezvanpour et al., 2011). Themembrane was probed with
5 nM A10A2 in TBS buffer (20 mM Tris and 150 mM NaCl [pH 7.0]) supple-
mented with 0.05% Tween-20 and 3% BSA for 2 hr and then rinsed with
TBS buffer supplemented with 0.05% Tween-20. Arrays were imaged using
an Odyssey imaging instrument (LI-COR Biosciences, Lincoln, NE, USA)
at 700 nm.
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